Clinical Trials Browser

INDUSTRY × Locally Advanced or Metastatic Solid Tumors × Clear all

Locally Advanced or Metastatic Solid Tumors

NCT07469774 2026-03-13

BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Not yet recruiting

111 enrolled

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT05012618 2025-12-24

A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

Phase 1 Terminated

128 enrolled

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT04511845 2025-07-14

A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

Phase 1 Active not recruiting

113 enrolled

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT06349811 2025-06-15

A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

30 enrolled

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT05830539 2025-05-02

IN10018 Combination Therapy in Previously-treated Locally Advanced or Metastatic Solid Tumor Patients

Phase 1/2 Completed

68 enrolled

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT06244992 2025-03-12

PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Recruiting

68 enrolled

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT06328439 2025-02-19

A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

264 enrolled

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT06293651 2025-02-12

Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Recruiting

125 enrolled

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT05116709 2024-12-27

Assessment of Safety and Preliminary Clinical Efficacy with BAT6005 in Advanced Malignant Solid Tumors

Phase 1 Completed

28 enrolled

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT06246071 2024-02-07

ASOTIAPWST

Phase 1 Recruiting

156 enrolled

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT04564417 2024-01-31

First-In-Human (FIH) Study of W0180 as Single Agent and in Combination With Pembrolizumab in Adults With Locally Advanced or Metastatic Solid Tumors

Phase 1 Terminated

33 enrolled

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT05360381 2023-08-08

HLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid Tumors

Phase 1 Unknown

82 enrolled

Other solid neoplasmThoracic

Locally Advanced or Metastatic Solid Tumors

NCT04128423 2021-10-19

Study of AMV564 in Subjects With Advanced Solid Tumors

Phase 1 Unknown

65 enrolled

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT03736850 2021-01-12

Study of CS3006 in Subjects With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

17 enrolled

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT03478995 2020-05-11

Study to Evaluate Safety and Tolerability of GX-I7 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

35 enrolled

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT01021748 2018-08-07

A Combination Therapy Study of MK-2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010)

Phase 1 Completed

63 enrolled 17 charts

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

Clinical Trials

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors

IN10018 Combination Therapy in Previously-treated Locally Advanced or Metastatic Solid Tumor Patients

PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors

A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors

Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors

Assessment of Safety and Preliminary Clinical Efficacy with BAT6005 in Advanced Malignant Solid Tumors

ASOTIAPWST

First-In-Human (FIH) Study of W0180 as Single Agent and in Combination With Pembrolizumab in Adults With Locally Advanced or Metastatic Solid Tumors

HLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid Tumors

Study of AMV564 in Subjects With Advanced Solid Tumors

Study of CS3006 in Subjects With Locally Advanced or Metastatic Solid Tumors

Study to Evaluate Safety and Tolerability of GX-I7 in Patients With Locally Advanced or Metastatic Solid Tumors

A Combination Therapy Study of MK-2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010)